Senior insider sale
Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.17M
37.12K shares
What this filing means
GOFF BRIAN plans to sell 37.12K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $1.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2026ACC: 0001439222-26-000055
DirectorOfficer· Chief Executive Officer
Since Mar 2026
37.12K
Shares to sell
$1.17M
Approx. market value
19.07K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Not Applicable
4/2/2026
19.07KTotal acquired19.07K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/2/2026 | Vesting of Restricted Stock Units Not Applicable | 19.07K | — |
| Total | 19.07K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
18.05K
Market value
$522.9K
3/2/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
19.07K
Market value
$651.9K
4/2/2026
Total
Units
37.12K
Value
$1.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 18.05K | $522.9K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2026 | 19.07K | $651.9K | Nasdaq | Planned |
| Total | 37.12K | $1.17M | ||